Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Combining Menin and MEK Inhibition to Target Poor Prognostic KMT2A -Rearranged RAS Pathway-Mutant Acute Leukemia

Nastassja Scheidegger, Gabriela Alexe, Delan Khalid, Rhonda E Ries, Jim Wang, Todd A. Alonzo, Jennifer Perry, Scott A Armstrong, Soheil Meshinchi, Yana Pikman, Kimberly Stegmaier

Blood (2023) 142 (Supplement 1): 166.

https://doi.org/10.1182/blood-2023-185561

Published: 2023

Journal Articles

Berkeley Sickle Cell Disease Mice Exhibit Multifaceted Immune Hyper-Activation, and Avidly Reject Allogeneic Bone Marrow Transplantation.

Leslie S. Kean, MD, PhD, Kelly Hamby, Jennifer Perry, David R. Archer, PhD

Blood (2007) 110 (11): 2251.

https://doi.org/10.1182/blood.V110.11.2251.2251

Published: 2007

Journal Articles

Effects of Sickle Cell Disease on Hematopoietic Stem Cell Function and the Bone Marrow Microenvironment.

Elisabeth H. Javazon, PhD, Leslie S. Kean, MD, PhD, Jennifer Perry, BS, Jessica Butler, BS, David R. Archer, PhD

Blood (2006) 108 (11): 1227.

https://doi.org/10.1182/blood.V108.11.1227.1227

Published: 2006

Journal Articles

Berkeley Sickle Mice Demonstrate CD8- and NK1.1-Dependent Increased Rejection of Allogeneic Hematopoietic Stem Cell Transplants.

Leslie Kean, MD, PhD, Kelly Hamby, Jennifer Perry, Christian Larsen, MD/PhD, David Archerq, PhD

Blood (2005) 106 (11): 2332.

https://doi.org/10.1182/blood.V106.11.2332.2332

Published: 2005

Journal Articles

Vascular Abnormalities and Pulmonary Hypertension in the Berkeley Sickle Mouse.

David R. Archer, PhD, Shawn Elms, PhD, Joshua Boutwell, BS, Jennifer Perry, BS, Roy Sutliff, PhD

Blood (2005) 106 (11): 3185.

https://doi.org/10.1182/blood.V106.11.3185.3185

Published: 2005

Journal Articles

Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease

Leslie S. Kean, Elizabeth A. Manci, Jennifer Perry, Can Balkan, Shana Coley, David Holtzclaw, Andrew B. Adams, Christian P. Larsen, Lewis L. Hsu, David R. Archer

Blood (2003) 102 (13): 4582–4593.

https://doi.org/10.1182/blood-2003-03-0712

Published: 2003

NARROW

Combining Menin and MEK Inhibition to Target Poor Prognostic KMT2A -Rearranged RAS Pathway-Mutant Acute Leukemia

Berkeley Sickle Cell Disease Mice Exhibit Multifaceted Immune Hyper-Activation, and Avidly Reject Allogeneic Bone Marrow Transplantation.

Effects of Sickle Cell Disease on Hematopoietic Stem Cell Function and the Bone Marrow Microenvironment.

Berkeley Sickle Mice Demonstrate CD8- and NK1.1-Dependent Increased Rejection of Allogeneic Hematopoietic Stem Cell Transplants.

Vascular Abnormalities and Pulmonary Hypertension in the Berkeley Sickle Mouse.

Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Combining Menin and MEK Inhibition to Target Poor Prognostic KMT2A -Rearranged RAS Pathway-Mutant Acute Leukemia

Berkeley Sickle Cell Disease Mice Exhibit Multifaceted Immune Hyper-Activation, and Avidly Reject Allogeneic Bone Marrow Transplantation.

Effects of Sickle Cell Disease on Hematopoietic Stem Cell Function and the Bone Marrow Microenvironment.

Berkeley Sickle Mice Demonstrate CD8- and NK1.1-Dependent Increased Rejection of Allogeneic Hematopoietic Stem Cell Transplants.

Vascular Abnormalities and Pulmonary Hypertension in the Berkeley Sickle Mouse.

Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only